1Maulana Azad Medical College, New Delhi, India
2Sri Ramachandra Institute of Higher Education and Research, Chennai, India
3Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, India
4Howard County Center for Lung and Sleep Medicine, Columbia, MD, USA
5Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, India
6Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA
7Penn State Milton S. Hershey Medical Center, Hershey, PA, USA
© 2024 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
FUNDING
None.
ACKNOWLEDGMENTS
None.
AUTHOR CONTRIBUTIONS
Conceptualization: JM, BS. Visualization: JM, BS. Project administration: JM. Writing–original draft: LG, MNS, JM, BS, VB. Writing–review & editing: VB, VG, RJ.
Study | Drug | Use | Mechanism |
---|---|---|---|
Bryant et al. [36] | Magnesium sulphate | Neuroprotective | Blockage of N-methyl-D-aspartate channels and voltage-gated calcium channels |
McIntosh et al. [37] | Disodium 2,4-disulfophenyl-N-tert-butylnitrone (NXY-059) | Antioxidant effects and vascular protective properties | Free radical scavenger |
Shuaib et al. [38] | Melatonin | Neuroprotective agent and maintenance of circadian rhythm | Alteration of catalase, glutathione peroxidase, and superoxide dismutase; and attenuation of the activation of nuclear factor-kappa B and activator protein 1 |
Shuaib et al. [38] | Curcumin | Anti-inflammatory, anti-oxidant, analgesic, and hepatoprotective properties | Reduction in the expression of matrix metalloproteinases, attenuation of interleukin-1, and inhibition of p38 mitogen-activated protein kinases/protein kinase C pathways |
Panahi et al. [39] | Citicoline | Neuroprotective | Increase activity of glutathione reductase, lipid peroxidation attenuation, increase of sirtuin 1 expression |
Hurtado et al. [40] |
ABCDEF bundle |
---|
A: Assess and manage pain |
B: Both spontaneous awakening trials and spontaneous breathing trials |
C: Choice of sedation and analgesia |
D: Delirium assessment and management |
E: Early mobility and exercise |
F: Family engagement and empowerment |
Study | Drug | Use | Mechanism |
---|---|---|---|
Bryant et al. [36] | Magnesium sulphate | Neuroprotective | Blockage of N-methyl-D-aspartate channels and voltage-gated calcium channels |
McIntosh et al. [37] | Disodium 2,4-disulfophenyl-N-tert-butylnitrone (NXY-059) | Antioxidant effects and vascular protective properties | Free radical scavenger |
Shuaib et al. [38] | Melatonin | Neuroprotective agent and maintenance of circadian rhythm | Alteration of catalase, glutathione peroxidase, and superoxide dismutase; and attenuation of the activation of nuclear factor-kappa B and activator protein 1 |
Shuaib et al. [38] | Curcumin | Anti-inflammatory, anti-oxidant, analgesic, and hepatoprotective properties | Reduction in the expression of matrix metalloproteinases, attenuation of interleukin-1, and inhibition of p38 mitogen-activated protein kinases/protein kinase C pathways |
Panahi et al. [39] | Citicoline | Neuroprotective | Increase activity of glutathione reductase, lipid peroxidation attenuation, increase of sirtuin 1 expression |
Hurtado et al. [40] |
Differential diagnosis |
---|
1. Stroke |
2. Endocrine abnormalities |
3. Alzheimer disease |
4. Severe depression |
5. Spine disorders |
6. Post–COVID-19 syndrome |
7. Myopathies |
8. Neuropathies |
9. Nutritional deficiencies |
10. Electrolyte abnormalities |
PICS: post-intensive care syndrome.
COVID-19: coronavirus disease 2019.